Effects of Active Hexose Correlated Compound (AHCC) on the onset of diabetes were studied in rats treated with streptozotocin (STZ). AHCC was given to male rats at 4% in drinking water. A single i.Y. injection of STZ (40 mg/k.g body weight) to rats resulted in an increase in blood glucose levels, a decrease in serum insulin levels, suppression of body weight gain. and an increase in serum GOT and OPT activities and serum levels of lipid peroxides. Treatment of AHCC restored these parameters to normal. Insulin immunoreactive p-cells in Langerhans islets reduced in number after treatment with STZ, while insulin immunoreactivity in the islets was normalized when AHCC was administered to STZ-treated rats. These results show that AHCC treatment is effective on the prevention of diabetes onset induced by STZ.
immunoreactivity in the islets was normalized when AHCC was administered to STZ-treated rats. These results show that AHCC treatment is effective on the prevention of diabetes onset induced by STZ.
Crude extracts derived from fungi of Basidiomycetes family such as lingzhi ( Ganoderma lucidum, reishi) and zhuling (Po/yporus umMOatus, chorei) are still used as components of Chinese traditional medicine. These fungi contain polysaccharides as well as other bioactive substances whose actions include regulation of the immune system, antitumor action, hypoglycemic effect, improvement of lipid metabolism and diuretic effect (26) .
Recent advances in culture techniques have enabled us to culture various species of Basidiomycetes. Active Hexose Correlated Compound (AHCCTM, Amino UP Chemical Co. Ltd., Sappro) is a mixture of polysaccharides, amino acids and minerals derived from fungi. It is obtained by hot water extraction after culturing mycelia of several basidiomycetes in a liquid culture tank and then treating them with some Correspondence to: Dr .K.oji Wakame at the above address. Tel: 028~87-2127, Fax: 0282-86-7268 1 enzymes (11) . AHCC has been successfully used as a biological response modifier (BRM) in various disorders but only a little is known about its mechanism of actions. Recently we have reported that AHCC has hepatoprotective and detoxicating effects due to induction of hepatic enzymes and antioxidant action (23) . It was also found that AHCC prolonged the life span and stimulated cytokine secretion from macrophages in mice bearing SST -2 tumor when treated together with 5-fluorouracil (5-FU) (14) . Furthermore, it was shown that AHCC was effective in preventing lung metastasis in breast cancer-bearing mice when treated simultaneously with 5-FU (14). Sun et al (13, 22) described that AHCC diminished the side-effects caused by antitumor agents such as cyclopho.sphamide, 5-FU and cytosine arabinoside. In other words, the disorders in hematopoietic function, depilation and hepatotoxicity induced by these pharmaceuticals were all ameliorated by AHCC. These results suggest that AHCC restores the depression of the immune system and reduces side-effects caused by antitumor agents, resulting in the prolongation of life span in experimental animals.
It is reponed that AHCC treatment for 2 years of patients with hepatoma who had undergone hepatectomy suppressed the remission and prolonged their life span significantly when compared with control patients (10). Yagita et aL (28) found that oral administration of AHCC to patients with malignant tumors resulted in an increase in serum levels of tumor necrosis factor (TNF)-a, interfcron-y, and intcrleukin-12 and a decrease in serum immunosupressive acidic protein (lAP) and tumor growth factor (TGF)·,B levels.
AHCC has clinically shown to be beneficial for the treatment of other diseases. In addition to patients with malignant tumors (28), diabetic patients have been shown to respond to AHCC (11). Polysaccharides which lower elevated blood glucose levels were found in several fungi. For example, ganoderan A, B and C, polysaccharides derived from Ganoderma luc/dum have hypoglycemic activity in alloxan-treated mice (24) .1t is not known whether or not AHCC contain such anti-diabetogenic polysaccharides.
In diabetes, the metabolism of glucose. proteins and lipids is abnormal due to the deficit in glucagon and insulin secretion, leading to various metabolic disorders ( 4) and onset of complications (8, 21 ) . It is also reported that diabetics are b.ighly sensitive to oxidative stress (1, 17, 25) .
The objective of the present study is to examine the preventive effects of AHCC on the onset of diabetes in rats treated with streptozotocin (STZ (Sapporo, Japan).
Animals.
Male Wistar rats of 4 weeks old were purchased from Charles River Japan Inc. (Kanagawa, Japan). The animals were housed in a room kept at 22±2·c with 12 b light and dark cycle (light on 8: oo-20: 00 h) and kept free acoess to food and water. The general conditions of the rats were observed every day. The amount of water intake was measured by subtracting the amount of residual of water from that measured the previous day.
A group ofrats were given only AHCC at 4%
in their drinking water for 3 weeks (AHCCtreated group). STZ at a dose of 40 mg per kg body weight was injected through the tail vein to 2 groups ofrats (STZ.treated group). One of the STZ-trcated groups received 4% AHCC in drink· ing water for one week prior to the treatment and 
RESULTS

General conditions
Poor general conditions such as depilation and deterioration in quality of fur were noticed in the STZ-treated group. AHCC treatment resulted in an improvement of these conditions. AHCC alone showed no effect on body weight changes.
A significant decrease in body weight gain was observed during 14 days after STZ treatment when compared with intact controls (Fig. 2) . The body weight gain of the STZ-AHCC treated rats was nearly the same as that of the intact control.
• 
Water intake Biochemical analy!es
An increase in the daily water consumption was noticed in the STZ-treated group (Fig. 3) . AHCC given alone increased somewhat the water consumption but decreased the increased water intake when given to the STZ-treated rats. A significant rise in blood glucose levels was observed in the STZ-treattd group up to 14th day' after the drug treatment, reaching its maximum on 7 days after the treatment (Fig. 4) . The blood glucose level at 14 days after STZ treatment was more than twice that in the control group. AHCC treatment nearly normalized the elevated levels of blood glucose in STZ-treated rats. The serum insulin levels decreased following STZ treatment and remained low till 14 days (Fig. 5) . AHCC treatment restored the decreased insulin levels to normal. The serum levels of GOT, GPT and LPO were greater in the STZ-treated group than in the intact control and STZ-AHCC treated group at 14 days after the treatments (Fig. 6 
Histology of the pancreas
A prominent decrease in the number of ,8-<:ells in the islets of Langerhans was observed in the STZ-treated group when compared with the control group (Figs. 7a and 7b) . The immunoreactivity of insulin in p-cells was markedly reduced or absent in the STZ-treated group (Fig.   7b) , whereas an appreciable immunoreactivity of insulin was detected in the p-cells of the STZ- 
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AHCC treated group (Fig. ?c) . The present study showed that the body weight of the STZ-treated rats decreased soon after STZ administration. This finding was in close agreement with that of other investigators (2, 3, 7, 12) . In the STZ-AHCC treated group, however, no significant decrease in body weight was observed, suggesting that AHCC normalized the weight change caused by STZ.
A significant increase in water intake, one of the general signs of diabetes, was observed in the STZ-treated rats. The water consumption was a little greater in the AHCC-treated groups than in the control, presumably because the rats had preference to AHCC-containing water which is rich in polysaccharides, amino acids, lipids and minerals. The water consumption of the STZtreated group is much greater tban tbat of the AHCC-treated groups. AHCC nearly normalized the water consumption and body weight gain of STZ-treated rats, suggesting that AHCC may have prevented the onset of diabetes.
In tbe STZ-treated group, blood glucose rose immediately after the treatment and reached a quite high level at 14th day. The serum insulin levels decreased significantly in the STZ-treated group, indicating that their pancreatic p-cells were damaged. On the other hand, the blood glucose levels in the STZ-AHCC treated group were much lower than in STZ-treated group but slightly higher than in the control group. These results showed that mild diabetes did occur in the STZ-AHCC-treated rats, even though the serum insulin levels were restored to normal in STZ-AHCC treated rats.
The serum levels of GOT, GPT and LPO increased in the STZ-treated group, while they were normalized by AHCC treatment. Rhee et al (20) reported that the increase in the serum levels of GOT, GPT and LPO was due to the oxidative damage in the pancreas, liver, kidney and other organs caused by STZ through the increase in the free radical production. They suggested that the production of free radicals was augmented by the increase in arachidonate concentrations and the activity of lipoxygenase and cyclooxygenase. Furthermore, they observed the suppressive effects of antioxidants such as vitamin Eon the onset of diabetes. The results of our present study suggest that AHCC suppresses the production of free radicals induced by STZ, whereby symptoms of diabetes were diminished.
Diabetogenic substances such as STZ preferentially destroy nuclei of ,8-cells. Apoptosis has recently been suggested to be involved in STZinduced degeneration of islet cells ( 15). Since ,B-cells of the islets decreased in number, one can expect that apoptosis may have occurred following STZ administration. The STZ-induced decrease in insulin immunoreactivity in islet 7 151 ,B-cells was restored by AHCC. These findings suggest that AHCC prevents cellular damage induced by STZ and preserve the capability of insulin secretion.
In conclusion, the results of our present study show that AHCC can prevent the onset of STZ~ induced diabetes by protecting p-cells from degeneration and by diminishing oxidative injuries of cells in various organs. It remains to be clarified the mechanism by which AHCC acts as an antioxidant.
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